Pharma
The funding brings the Munich-based startup's total Series B raise to €42 million.
PointClickCare's senior health-focused datasets will help to influence Pfizer's decisions on new therapies.
The partnership will offer one platform for clinical trial sponsors, sites and participants.
The alliance will expand Sanofi's trek into tech-based drug discovery and development platforms.
Mati Gil, CEO of AION Labs, describes how its new startup OMEC.AI came to fruition and what it aims to accomplish for drug discovery and development.
Device Connect for Fitbit aims to help healthcare and life science organizations use and analyze data from Fitbit's health-tracking wearables.
nference said researchers can use the de-identified clinical data to develop new therapeutics and diagnostics.
The company announced a $200 million Series C round in January.
The company said the clearance will allow more pharma companies to use Tasso+ for decentralized clinical trials.
The partnership will allow Withings' connected scales, blood pressure monitors and sleep-tracking mats to integrate with Medable's trial platform.